NDC 64406-808
ELOCTATE
Antihemophilic Factor (recombinant), Fc Fusion Protein
ELOCTATE is a Intravenous Kit in the Plasma Derivative category. It is labeled and distributed by Biogen Inc.. The primary component is .
| Product ID | 64406-808_687cc397-4d4c-4188-9ad3-e164db291952 |
| NDC | 64406-808 |
| Product Type | Plasma Derivative |
| Proprietary Name | ELOCTATE |
| Generic Name | Antihemophilic Factor (recombinant), Fc Fusion Protein |
| Dosage Form | Kit |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2014-07-14 |
| Marketing End Date | 2021-01-31 |
| Marketing Category | BLA / BLA |
| Application Number | BLA125487 |
| Labeler Name | Biogen Inc. |
| Active Ingredient Strength | 0 |
| NDC Exclude Flag | N |
Packaging
NDC 64406-808-01
1 KIT in 1 KIT (64406-808-01) * 3 mL in 1 VIAL (64406-490-08) * 3 mL in 1 VIAL (64406-035-01)
| Marketing Start Date | 2014-07-14 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 64406-808-01 [64406080801]
ELOCTATE KIT
| Marketing Category | BLA |
| Application Number | BLA125487 |
| Product Type | PLASMA DERIVATIVE |
| Billing Unit | EA |
| Marketing Start Date | 2014-07-14 |
| Inactivation Date | 2020-01-31 |
Drug Details
NDC Crossover Matching brand name "ELOCTATE" or generic name "Antihemophilic Factor (recombinant), Fc Fusion Protein"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 64406-801 | ELOCTATE | Antihemophilic Factor (Recombinant), Fc Fusion Protein |
| 64406-802 | ELOCTATE | Antihemophilic Factor (Recombinant), Fc Fusion Protein |
| 64406-803 | ELOCTATE | Antihemophilic Factor (Recombinant), Fc Fusion Protein |
| 64406-804 | ELOCTATE | Antihemophilic Factor (Recombinant), Fc Fusion Protein |
| 64406-805 | ELOCTATE | Antihemophilic Factor (Recombinant), Fc Fusion Protein |
| 64406-806 | ELOCTATE | Antihemophilic Factor (Recombinant), Fc Fusion Protein |
| 64406-807 | ELOCTATE | Antihemophilic Factor (Recombinant), Fc Fusion Protein |
| 64406-808 | ELOCTATE | Antihemophilic Factor (Recombinant), Fc Fusion Protein |
| 64406-809 | ELOCTATE | Antihemophilic Factor (Recombinant), Fc Fusion Protein |
| 64406-810 | ELOCTATE | Antihemophilic Factor (Recombinant), Fc Fusion Protein |
| 71104-801 | ELOCTATE | Antihemophilic Factor (Recombinant), Fc Fusion Protein |
| 71104-802 | ELOCTATE | Antihemophilic Factor (Recombinant), Fc Fusion Protein |
| 71104-803 | ELOCTATE | Antihemophilic Factor (Recombinant), Fc Fusion Protein |
| 71104-804 | ELOCTATE | Antihemophilic Factor (Recombinant), Fc Fusion Protein |
| 71104-805 | ELOCTATE | Antihemophilic Factor (Recombinant), Fc Fusion Protein |
| 71104-806 | ELOCTATE | Antihemophilic Factor (Recombinant), Fc Fusion Protein |
| 71104-807 | ELOCTATE | Antihemophilic Factor (Recombinant), Fc Fusion Protein |
| 71104-810 | ELOCTATE | ELOCTATE |
| 71104-808 | ELOCTATE | ELOCTATE |
| 71104-809 | ELOCTATE | ELOCTATE |
Trademark Results [ELOCTATE]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 ELOCTATE 86310235 4671661 Live/Registered |
BIOVERATIV THERAPEUTICS INC. 2014-06-16 |
 ELOCTATE 85411822 4645453 Live/Registered |
BIOVERATIV THERAPEUTICS INC. 2011-08-31 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.